{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:44:03Z","timestamp":1793047443838,"version":"4.5.0"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi240072-4\"><jats:title>Importance<\/jats:title><jats:p>Depression is among the most common comorbidities in rheumatoid arthritis (RA). There is a lack of data regarding the association of RA seropositivity and biologic agents with depression risk among individuals with RA.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi240072-5\"><jats:title>Objective<\/jats:title><jats:p>To investigate the risk of depression following RA diagnosis among patients in South Korea.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi240072-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This retrospective cohort study included 38\u202f487 patients with RA and a comparison group of 192\u202f435 individuals matched 1:5 for age, sex, and index date. Data were from the Korean National Health Insurance Service database. Participants were enrolled from 2010 to 2017 and were followed up until 2019. Participants who had previously been diagnosed with depression or were diagnosed with depression within 1 year after the index date were excluded. Statistical analysis was performed in May 2023.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi240072-7\"><jats:title>Exposures<\/jats:title><jats:p>Seropositive RA (SPRA) was defined with the <jats:italic>International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10)<\/jats:italic> codes M05 and enrollment in the Korean Rare and Intractable Diseases program. Seronegative RA (SNRA) was defined with <jats:italic>ICD-10<\/jats:italic> codes M06 (excluding M06.1 and M06.4) and a prescription of any disease-modifying antirheumatic drugs (DMARDs) for 270 days or more.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi240072-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Newly diagnosed depression (<jats:italic>ICD-10<\/jats:italic> codes F32 or F33).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi240072-9\"><jats:title>Results<\/jats:title><jats:p>The mean (SD) age of the total study population was 54.6 (12.1) years, and 163\u202f926 individuals (71.0%) were female. During a median (IQR) follow-up of 4.1 (2.4-6.2) years, 27\u202f063 participants (20\u202f641 controls and 6422 with RA) developed depression. Participants with RA had a 1.66-fold higher risk of depression compared with controls (adjusted hazard ratio [aHR], 1.66 [95% CI, 1.61-1.71]). The SPRA group (aHR, 1.64 [95% CI, 1.58-1.69]) and the SNRA group (aHR, 1.73 [95% CI, 1.65-1.81]) were associated with an increased risk of depression compared with controls. Patients with RA who used biologic or targeted synthetic DMARDs (aHR, 1.33 [95% CI, 1.20-1.47]) had a lower risk of depression compared with patients with RA who did not use these medications (aHR, 1.69 [95% CI, 1.64-1.74]).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi240072-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This nationwide cohort study found that both SPRA and SNRA were associated with a significantly higher risk of depression. These results suggest the importance of early screening and intervention for mental health in patients with RA.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.1139","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T16:17:48Z","timestamp":1709655468000},"page":"e241139","source":"Crossref","is-referenced-by-count":30,"title":["Rheumatoid Arthritis and Risk of Depression in South Korea"],"prefix":"10.1001","volume":"7","author":[{"given":"Keun Hye","family":"Jeon","sequence":"first","affiliation":[{"name":"Department of Family Medicine, CHA Gumi Medical Center, CHA University School of Medicine, Gumi, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhyoung","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Il","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonghee","family":"Eun","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Wook","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Family Medicine\/Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea"},{"name":"Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyungjin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea"},{"name":"Department of Medical Humanities, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"issue":"10159","key":"zoi240072r1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"zoi240072r2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/annrheumdis-2013-204223","article-title":"Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).","volume":"73","author":"Dougados","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"zoi240072r3","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1093\/rheumatology\/ket169","article-title":"The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis.","volume":"52","author":"Matcham","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"zoi240072r4","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1093\/rheumatology\/kes356","article-title":"The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review.","volume":"52","author":"Rathbun","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"zoi240072r5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/apl.v23.3","article-title":"Depression has an impact on disease activity and health-related quality of life in rheumatoid arthritis: a systematic review and meta-analysis.","volume":"23","author":"Zhang","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"zoi240072r6","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X221111613","article-title":"The association of depression and anxiety with treatment outcomes in patients with rheumatoid arthritis - a pooled analysis of five randomised controlled trials.","author":"Manning-Bennett","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"5","key":"zoi240072r7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/rheumatology\/kex528","article-title":"The relationship between depression and biologic treatment response in rheumatoid arthritis: an analysis of the British Society for Rheumatology Biologics Register.","volume":"57","author":"Matcham","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"zoi240072r8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.genhosppsych.2009.04.001","article-title":"Depression increases risk of incident myocardial infarction among Veterans Administration patients with rheumatoid arthritis.","volume":"31","author":"Scherrer","year":"2009","journal-title":"Gen Hosp Psychiatry"},{"key":"zoi240072r9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.genhosppsych.2018.06.001","article-title":"Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases.","volume":"53","author":"Marrie","year":"2018","journal-title":"Gen Hosp Psychiatry"},{"issue":"6","key":"zoi240072r10","first-page":"1013","article-title":"Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis.","volume":"32","author":"Ang","year":"2005","journal-title":"J Rheumatol"},{"issue":"1","key":"zoi240072r11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/acr.v73.1","article-title":"Impact of psychiatric comorbidity on health care use in rheumatoid arthritis: a population-based study.","volume":"73","author":"Hitchon","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"zoi240072r12","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1093\/rheumatology\/kez559","article-title":"Association between depression and rheumatoid arthritis: two longitudinal follow-up studies using a national sample cohort.","volume":"59","author":"Kim","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"zoi240072r13","doi-asserted-by":"publisher","first-page":"20647","DOI":"10.1038\/srep20647","article-title":"Bidirectional associations between rheumatoid arthritis and depression: a nationwide longitudinal study.","volume":"6","author":"Lu","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"zoi240072r14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.6061\/clinics\/2015(02)04","article-title":"Increased risk of depression in patients with rheumatoid arthritis: a seven-year population-based cohort study.","volume":"70","author":"Lin","year":"2015","journal-title":"Clinics (Sao Paulo)"},{"issue":"9","key":"zoi240072r15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107791","article-title":"Risk of developing depressive disorders following rheumatoid arthritis: a nationwide population-based study.","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"zoi240072r16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11136-016-1387-2","article-title":"Depression risk in patients with late-onset rheumatoid arthritis in Germany.","volume":"26","author":"Drosselmeyer","year":"2017","journal-title":"Qual Life Res"},{"issue":"7","key":"zoi240072r17","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/acr.v70.7","article-title":"Increased burden of psychiatric disorders in rheumatoid arthritis.","volume":"70","author":"Marrie","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"zoi240072r19","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1001\/jamaneurol.2023.0932","article-title":"Rheumatoid arthritis and risk of Parkinson disease in Korea.","volume":"80","author":"Kang","year":"2023","journal-title":"JAMA Neurol"},{"issue":"6","key":"zoi240072r20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ophtha.2023.01.014","article-title":"Impact of age-related macular degeneration and related visual disability on the risk of depression: a nationwide cohort study.","volume":"130","author":"Hwang","year":"2023","journal-title":"Ophthalmology"},{"issue":"1","key":"zoi240072r21","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/ijerph20010842","article-title":"Increased risk of developing depression in disability after stroke: a Korean nationwide study.","volume":"20","author":"Choi","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"zoi240072r22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.55563\/clinexprheumatol\/go7g26","article-title":"Seronegative rheumatoid arthritis: one year in review 2023.","volume":"41","author":"De Stefano","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"zoi240072r23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.berh.2014.10.016","article-title":"Seronegative rheumatoid arthritis: pathogenetic and therapeutic aspects.","volume":"28","author":"Pratt","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"13","key":"zoi240072r24","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review.","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"zoi240072r25","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001290","article-title":"Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBIT.","volume":"6","author":"Sch\u00e4fer","year":"2020","journal-title":"RMD Open"},{"key":"zoi240072r26","doi-asserted-by":"publisher","author":"Bugatti","journal-title":"Ther Adv Musculoskelet Dis","DOI":"10.1177\/1759720X211011826"},{"issue":"8","key":"zoi240072r27","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/rheumatology\/key112","article-title":"Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis.","volume":"57","author":"Duffield","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"zoi240072r28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/00006842-200201000-00008","article-title":"Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis.","volume":"64","author":"Dickens","year":"2002","journal-title":"Psychosom Med"},{"issue":"2","key":"zoi240072r29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S2215-0366(18)30255-4","article-title":"Rheumatoid arthritis and depression: an inflammatory perspective.","volume":"6","author":"Nerurkar","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"8","key":"zoi240072r30","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.drudis.2015.05.003","article-title":"Clinical implications of leukocyte infiltration at the choroid plexus in (neuro)inflammatory disorders.","volume":"20","author":"Demeestere","year":"2015","journal-title":"Drug Discov Today"},{"issue":"12","key":"zoi240072r31","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1046\/j.1532-5415.2002.50619.x","article-title":"Cytokines and cognition\u2013the case for a head-to-toe inflammatory paradigm.","volume":"50","author":"Wilson","year":"2002","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"zoi240072r32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"zoi240072r33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1006\/brbi.1995.1026","article-title":"Regulation of the HPA axis by cytokines.","volume":"9","author":"Turnbull","year":"1995","journal-title":"Brain Behav Immun"},{"issue":"3","key":"zoi240072r34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12264-013-1439-3","article-title":"Inflammation: a mechanism of depression?","volume":"30","author":"Han","year":"2014","journal-title":"Neurosci Bull"},{"issue":"4","key":"zoi240072r35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5152\/eurjrheumatol.","article-title":"Combined infliximab and methotrexate treatment improves the depressive state in rheumatoid arthritis patients more effectively than methotrexate alone.","volume":"1","author":"Miwa","year":"2014","journal-title":"Eur J Rheumatol"},{"issue":"3","key":"zoi240072r36","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10067-019-04820-x","article-title":"Risk factors, including different biologics, associated with depression and anxiety in patients with rheumatoid arthritis: a cross-sectional observational study.","volume":"39","author":"Ng","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"1","key":"zoi240072r37","first-page":"30","article-title":"Tumor necrosis factor inhibitor therapy and the risk for depression among working-age adults with rheumatoid arthritis.","volume":"12","author":"Deb","year":"2019","journal-title":"Am Health Drug Benefits"},{"issue":"9","key":"zoi240072r38","doi-asserted-by":"publisher","DOI":"10.1111\/eci.v50.9","article-title":"The impact of tocilizumab on anxiety and depression in patients with rheumatoid arthritis.","volume":"50","author":"Tiosano","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"zoi240072r39","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5954897","article-title":"Influence of biological therapeutics, cytokines, and disease activity on depression in rheumatoid arthritis.","volume":"2018","author":"Figueiredo-Braga","year":"2018","journal-title":"J Immunol Res"},{"issue":"9","key":"zoi240072r40","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/art.2018.70.issue-9","article-title":"The impact of targeted rheumatoid arthritis pharmacologic treatment on mental health: a systematic review and network meta-analysis.","volume":"70","author":"Matcham","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"zoi240072r41","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102528","article-title":"Rheumatoid arthritis in the elderly: characteristics and treatment considerations.","volume":"19","author":"Serhal","year":"2020","journal-title":"Autoimmun Rev"},{"key":"zoi240072r42","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jad.2022.05.108","article-title":"Elucidating a bidirectional association between rheumatoid arthritis and depression: a systematic review and meta-analysis.","volume":"311","author":"Ng","year":"2022","journal-title":"J Affect Disord"},{"key":"zoi240072r18","volume-title":"Precis Future Med","author":"Shin","year":"2022"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2815685\/jeon_2024_oi_240072_1708613279.50102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T16:17:52Z","timestamp":1709655472000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2815685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.1139","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,5]]}}}